Erfonrilimab
Erfonrilimab (KN-046) is an anti-PDL1/CTLA-4 monoclonal antibody[1].
Product Specifications
CAS Number
[2367013-69-0]
Product Name Alternative
KN-046
UNSPSC
12352203
Target
CTLA-4; PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/erfonrilimab.html
Purity
99.98
Smiles
[Erfonrilimab]
Molecular Weight
(107.13 kDa)
References & Citations
[1]Erfonrilimab
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6327044-01 0.2 mL
NUAK2 (NUAK2, OMPHK2, SNARK, NUAK family SNF1-like kinase 2, Omphalocele kinase 2, SNF1/AMP kinase-related kinase) (Azide free) (HRP)
Ask
View Details 
MBS6327044-02 5x 0.2 mL
NUAK2 (NUAK2, OMPHK2, SNARK, NUAK family SNF1-like kinase 2, Omphalocele kinase 2, SNF1/AMP kinase-related kinase) (Azide free) (HRP)
Ask
View Details